Open Access
Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment
Тип публикации: Journal Article
Дата публикации: 2011-05-13
scimago Q1
БС1
SJR: 2.224
CiteScore: 12.6
Impact factor: 9.1
ISSN: 01615505, 2159662X
PubMed ID:
21571797
Radiology, Nuclear Medicine and imaging
Краткое описание
Radiolabeled peptides have been an important class of compounds in radiopharmaceutical sciences and nuclear medicine for more than 20 years. Despite strong research efforts, only somatostatin-based radiopeptides have a real impact on patient care, diagnostically and therapeutically. [111In-diethylenetriaminepentaacetic acid0]octreotide is commercially available for imaging. Imaging was highly improved by the introduction of PET radionuclides such as 68Ga, 64Cu, and 18F. Two peptides are successfully used in targeted radionuclide therapy when bound to DOTA and labeled with 90Y and 177Lu.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
4
5
|
|
|
European Journal of Nuclear Medicine and Molecular Imaging
5 публикаций, 5.56%
|
|
|
Journal of Nuclear Medicine
4 публикации, 4.44%
|
|
|
Journal of Radioanalytical and Nuclear Chemistry
4 публикации, 4.44%
|
|
|
Radiochimica Acta
3 публикации, 3.33%
|
|
|
Nuclear Medicine Communications
3 публикации, 3.33%
|
|
|
Nuclear Medicine and Molecular Imaging
3 публикации, 3.33%
|
|
|
Advanced Drug Delivery Reviews
3 публикации, 3.33%
|
|
|
Nuclear Medicine and Biology
3 публикации, 3.33%
|
|
|
International Journal of Molecular Sciences
2 публикации, 2.22%
|
|
|
EJNMMI Research
2 публикации, 2.22%
|
|
|
Bioorganic Chemistry
2 публикации, 2.22%
|
|
|
Mendeleev Communications
1 публикация, 1.11%
|
|
|
Diagnostics
1 публикация, 1.11%
|
|
|
Oncotarget
1 публикация, 1.11%
|
|
|
Radiology
1 публикация, 1.11%
|
|
|
American Journal of Surgical Pathology
1 публикация, 1.11%
|
|
|
Molecules
1 публикация, 1.11%
|
|
|
Pharmaceuticals
1 публикация, 1.11%
|
|
|
Pharmaceutics
1 публикация, 1.11%
|
|
|
Genes
1 публикация, 1.11%
|
|
|
Journal of Personalized Medicine
1 публикация, 1.11%
|
|
|
Frontiers in Medicine
1 публикация, 1.11%
|
|
|
Frontiers in Chemistry
1 публикация, 1.11%
|
|
|
Frontiers in Genetics
1 публикация, 1.11%
|
|
|
Nature Chemical Biology
1 публикация, 1.11%
|
|
|
Cancer Imaging
1 публикация, 1.11%
|
|
|
Virchows Archiv
1 публикация, 1.11%
|
|
|
EJNMMI Radiopharmacy and Chemistry
1 публикация, 1.11%
|
|
|
Nature Reviews Urology
1 публикация, 1.11%
|
|
|
1
2
3
4
5
|
Издатели
|
5
10
15
20
25
|
|
|
Springer Nature
25 публикаций, 27.78%
|
|
|
Elsevier
18 публикаций, 20%
|
|
|
MDPI
10 публикаций, 11.11%
|
|
|
Society of Nuclear Medicine
4 публикации, 4.44%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
4 публикации, 4.44%
|
|
|
Wiley
4 публикации, 4.44%
|
|
|
De Gruyter Brill
3 публикации, 3.33%
|
|
|
Frontiers Media S.A.
3 публикации, 3.33%
|
|
|
American Chemical Society (ACS)
3 публикации, 3.33%
|
|
|
Royal Society of Chemistry (RSC)
2 публикации, 2.22%
|
|
|
Hindawi Limited
2 публикации, 2.22%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 1.11%
|
|
|
Impact Journals
1 публикация, 1.11%
|
|
|
Radiological Society of North America (RSNA)
1 публикация, 1.11%
|
|
|
Zhejiang University Press
1 публикация, 1.11%
|
|
|
Georg Thieme Verlag KG
1 публикация, 1.11%
|
|
|
AME Publishing Company
1 публикация, 1.11%
|
|
|
Centre for Evaluation in Education and Science (CEON/CEES)
1 публикация, 1.11%
|
|
|
Edizioni Minerva Medica
1 публикация, 1.11%
|
|
|
CSIRO Publishing
1 публикация, 1.11%
|
|
|
5
10
15
20
25
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
91
Всего цитирований:
91
Цитирований c 2025:
4
(4.44%)
Самый цитирующий журнал
Цитирований в журнале:
5
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Maecke H. R. Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment // Journal of Nuclear Medicine. 2011. Vol. 52. No. 6. pp. 841-844.
ГОСТ со всеми авторами (до 50)
Скопировать
Maecke H. R. Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment // Journal of Nuclear Medicine. 2011. Vol. 52. No. 6. pp. 841-844.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.2967/jnumed.110.084236
UR - https://doi.org/10.2967/jnumed.110.084236
TI - Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment
T2 - Journal of Nuclear Medicine
AU - Maecke, Helmut R.
PY - 2011
DA - 2011/05/13
PB - Society of Nuclear Medicine
SP - 841-844
IS - 6
VL - 52
PMID - 21571797
SN - 0161-5505
SN - 2159-662X
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2011_Maecke,
author = {Helmut R. Maecke},
title = {Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment},
journal = {Journal of Nuclear Medicine},
year = {2011},
volume = {52},
publisher = {Society of Nuclear Medicine},
month = {may},
url = {https://doi.org/10.2967/jnumed.110.084236},
number = {6},
pages = {841--844},
doi = {10.2967/jnumed.110.084236}
}
Цитировать
MLA
Скопировать
Maecke, Helmut R.. “Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment.” Journal of Nuclear Medicine, vol. 52, no. 6, May. 2011, pp. 841-844. https://doi.org/10.2967/jnumed.110.084236.